Search Legislation

The Medicines for Human Use (Clinical Trials) Regulations 2004

 Help about what version

What Version

 Help about advanced features

Advanced Features

 Help about opening options

Opening OptionsExpand opening options

Changes over time for: Paragraph 5

 Help about opening options

Alternative versions:

Status:

Point in time view as at 06/11/2023.

Changes to legislation:

The Medicines for Human Use (Clinical Trials) Regulations 2004, Paragraph 5 is up to date with all changes known to be in force on or before 04 March 2025. There are changes that may be brought into force at a future date. Changes that have been made appear in the content and are referenced with annotations. Help about Changes to Legislation

5.—(1) Section 23 of the Act (special provisions as to the effect of manufacturer’s licence) F1 shall be amended as follows.U.K.

(2) In subsection (1)—

(a)omit “clinical trials and”;

(b)for paragraph (b), substitute the following paragraph—

(b)the products are manufactured or assembled to the order of—

(i)a person who is the holder of such a product licence, or

(ii)if the products are to be used for the purposes of a clinical trial, the sponsor of that trial,.

(3) After subsection (5), insert the following subsection—

(6) In this section, “clinical trial” and “sponsor”, in relation to a clinical trial, have the meaning given by Clinical Trials Regulations..

Textual Amendments

F1Section 23 of the Act has effect as if any reference in subsection (1) to a product licence included a reference to a marketing authorization; see regulation 9(1) of the 1994 Regulations.

Back to top

Options/Help